Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of the escape phase of myeloma.

Blood reviews - 1 Mar 1994

Joshua D E, Gibson J, Brown R D

Abstract excerpt

In multiple myeloma the duration of plateau is an important clinical and biological determinant of quality of life and survival. During plateau phase, the tumour is in an indolent state, as manifested by a low labelling index of plasma cells and other proliferative markers, e.g. the thymidine kinase level. The mechanism by which plasma cells escape from this indolent phase to a more aggressive phase of this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Cell Division
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Membrane Proteins

Share to Mutation

Share to Oncogenes

Share to Prognosis

Source

Identifiers

PMID: 8205006
DOI: 10.1016/0268-960x(94)90003-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Mechanisms of the escape phase of myeloma.PMID 8205006Read ↗

Plasma cell dedifferentiation in refractory multiple myeloma.Semantic proximity Read ↗

The oncoprotein phenotype of plasma cells from patients with multiple myeloma.Semantic proximity Read ↗

Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcomeSemantic proximity Read ↗

The functional phenotype of the primitive plasma cell in patients with multiple myeloma correlates with the clinical state.Semantic proximity Read ↗

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal nicheSemantic proximity Read ↗

Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanismSemantic proximity Read ↗

Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.Semantic proximity Read ↗

Phenotypic characterization of the human myeloma cell growth fraction.Semantic proximity Read ↗

Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.